Venipuncture Procedure Market by Vein Type, End-User

List of Tables

The Venipuncture Procedure Market is projected to reach USD 1.84 billion by 2030 from USD 1.16 billion in 2022, at a CAGR of 5.96% during the forecast period.

Global Venipuncture Procedure Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 1.16 billion
Estimated Year Value [2023]	USD 1.22 billion
Forecast Year Value [2030]	USD 1.84 billion
CAGR (%)	5.96%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Venipuncture Procedure Market.

Based on Vein Type, market is studied across Basilic Vein, Cephalic Vein, and Median Cubital Vein. The Cephalic Vein is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Diagnostic Laboratories, Hospital, and Physician Offices/Clinics. The Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Venipuncture Procedure Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Venipuncture Procedure Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Venipuncture Procedure Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuVein Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, bioMerieux S.A., Cardinal Health, Inc., Christie Medical Holdings, Inc., Fresenius Medical Care AG & Co. KGaA, Henry Schein, Inc., Hindustan Syringes & Medical Devices Ltd., ICU Medical Inc., Kyoto Kagaku Co., Ltd., LUMITOS AG, Medline Industries, Inc., Merck KGaA, P. H. Healthcare Pvt. Ltd., Parker Hannifin Corporation, Sharn Inc., Thermo Fisher Scientific Inc., TransLite LLC, and Venoscope, LLC.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Venipuncture Procedure Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Venipuncture Procedure Market?

3. What is the competitive strategic window for identifying opportunities in the Venipuncture Procedure Market?

4. What are the latest technology trends and regulatory frameworks in the Venipuncture Procedure Market?

5. What is the market share of the leading vendors in the Venipuncture Procedure Market?

6. Which modes and strategic moves are suitable for entering the Venipuncture Procedure Market?

Product Code: MRR-FF012EDC38DF

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Venipuncture Procedure Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of chronic disorders globally
  - 5.1.1.2. Increased focus on R&D proficiencies by the pharmaceutical and biopharmaceutical industries
  - 5.1.1.3. Growing geriatric population and rising expenditure for the development of healthcare infrastructure
- 5.1.2. Restraints
  - 5.1.2.1. Lack of standardization in the developing and underdeveloped economies
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in the testing and diagnosing instruments
  - 5.1.3.2. Ongoing advancements in venipuncture procedures
- 5.1.4. Challenges
  - 5.1.4.1. Unfavorable reimbursement policies and lack of skilled medical professionals in developing countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Venipuncture Procedure Market, by Vein Type

6.1. Introduction
6.2. Basilic Vein
6.3. Cephalic Vein
6.4. Median Cubital Vein

7. Venipuncture Procedure Market, by End-User

7.1. Introduction
7.2. Diagnostic Laboratories
7.3. Hospital
7.4. Physician Offices/Clinics

8. Americas Venipuncture Procedure Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Venipuncture Procedure Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Venipuncture Procedure Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
- 12.1.1. Abbott Laboratories
- 12.1.2. AccuVein Inc.
- 12.1.3. B. Braun Melsungen AG
- 12.1.4. Becton, Dickinson and Company
- 12.1.5. bioMerieux S.A.
- 12.1.6. Cardinal Health, Inc.
- 12.1.7. Christie Medical Holdings, Inc.
- 12.1.8. Fresenius Medical Care AG & Co. KGaA
- 12.1.9. Henry Schein, Inc.
- 12.1.10. Hindustan Syringes & Medical Devices Ltd.
- 12.1.11. ICU Medical Inc.
- 12.1.12. Kyoto Kagaku Co., Ltd.
- 12.1.13. LUMITOS AG
- 12.1.14. Medline Industries, Inc.
- 12.1.15. Merck KGaA
- 12.1.16. P. H. Healthcare Pvt. Ltd.
- 12.1.17. Parker Hannifin Corporation
- 12.1.18. Sharn Inc.
- 12.1.19. Thermo Fisher Scientific Inc.
- 12.1.20. TransLite LLC
- 12.1.21. Venoscope, LLC
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing